S
Sarah E. Fowler
Researcher at George Washington University
Publications - 39
Citations - 28806
Sarah E. Fowler is an academic researcher from George Washington University. The author has contributed to research in topics: Diabetes mellitus & Metformin. The author has an hindex of 29, co-authored 36 publications receiving 27001 citations. Previous affiliations of Sarah E. Fowler include Henry Ford Hospital.
Papers
More filters
Journal ArticleDOI
Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions
Robert E. Ratner,Costas A. Christophi,Boyd E. Metzger,Dana Dabelea,Peter H. Bennett,Xavier Pi-Sunyer,Sarah E. Fowler,Steven E. Kahn +7 more
TL;DR: Progression to diabetes is more common in women with a history of GDM compared with those without GDM history despite equivalent degrees of IGT at baseline, and both intensive lifestyle and metformin are highly effective in delaying or preventing diabetes in Women with IGT and a historyof GDM.
Journal ArticleDOI
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
Robert E. Ratner,Ronald B. Goldberg,Steven M. Haffner,Santica Marcovina,Trevor J. Orchard,Sarah E. Fowler,Marinella Temprosa +6 more
TL;DR: Lifestyle intervention improves CVD risk factor status compared with placebo and metformin therapy and achieved risk factor modifications suggest that longer intervention may reduce CVD event rates.
Journal ArticleDOI
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
William C. Knowler,Richard F. Hamman,Sharon L. Edelstein,Elizabeth Barrett-Connor,David A. Ehrmann,Elizabeth A. Walker,Sarah E. Fowler,David M. Nathan,Steven E. Kahn +8 more
TL;DR: Troglitazone markedly reduced the incidence of diabetes during its limited period of use, but this action did not persist, and whether other thiazolidinedione drugs used for longer periods can safely prevent diabetes remains to be determined.
Journal ArticleDOI
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
Abbas E Kitabchi,Marinella Temprosa,William C. Knowler,Steven E. Kahn,Sarah E. Fowler,Steven M. Haffner,Reuben Andres,Christopher D. Saudek,Sharon L. Edelstein,Richard Arakaki,Mary Beth Murphy,Harry Shamoon +11 more
TL;DR: Higher insulin secretion and sensitivity at baseline and improvements in response to treatment were associated with lower diabetes risk in the DPP, suggesting the better preventive effectiveness of intensive lifestyle may be due to improved insulin sensitivity concomitant with preservation of beta-cell function.
Journal ArticleDOI
Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III).
Paul D. Stein,Thomas L. Chenevert,Sarah E. Fowler,Lawrence R. Goodman,Alexander Gottschalk,Charles A. Hales,Russell Hull,Kathleen A. Jablonski,Kenneth V. Leeper,David P. Naidich,Daniel J. Sak,H. Dirk Sostman,Victor F. Tapson,John G. Weg,Pamela K. Woodard +14 more
TL;DR: In this article, the authors tested whether magnetic resonance angiography in combination with venous phase-magnetic resonance venography might be useful for the diagnosis or exclusion of acute pulmonary embolism.